Introduction

Introduction

BUSINESS DEVELOPMENT

Cangene’s Business Development team actively seeks new opportunities that have the potential to make a difference in patient health. We evaluate opportunities to in-license products at all stages of development, acquire commercialized or recently approved products, or collaborate with partners to launch products within North America. Our primary targets for in-licensing and partnership opportunities are hospital-based specialty products, and orphan drugs.

Cangene brings leadership and extensive experience to any partnership. Our core competencies include:

Experienced Commercial Operations

U.S. sales and marketing capability with focus on hospital-based specialty products

Fully-integrated commercial infrastructure, including warehousing
Established contracts with major GPOs, wholesalers, distributors and managed-care organizations

Proven commercial operations in Canada

Relationships with major hospitals and infusion centers across the country

Clinical Development and R&D

Broad experience in advancing early-stage products
Experienced clinical development teams, including medical and scientific affairs with a proven track record for developing and executing clinical trials with clear endpoints;
Established regulatory track record with the U.S. Food and Drug Administration, Health Canada and with other regulatory bodies worldwide
FDA- and Heath Canada-licensed manufacturing and plasma-collection facilities

At Cangene, we take a flexible approach to partnering and deal structures. In each partnership, we work to further the goals and objectives of both parties, while advancing science and medicine for people around the world.

What Cangene looks for in a partnership:

Well-defined strategic fit
Well-validated market with growth opportunity
Promising pre-clinical and/or clinical data
Strong intellectual property position

To contact a representative from Cangene’s Business Development team, please Email: businessdevelopment@cangene.com.